CJC-1295 (No DAC) for Cognitive Enhancement
Research, mechanism, dosing, and effectiveness of CJC-1295 (No DAC) for cognitive enhancement.
Quick Answer
GH may support brain health and cognitive function.
Evidence Level
Human Trials
Typical Dose
100-200 mcg daily
Results Timeline
Cognitive effects over 4-8 weeks
FDA Status
Research Only
How CJC-1295 (No DAC) Works for Cognitive Enhancement
Growth hormone has effects on neuroplasticity.
About Cognitive Enhancement
Improvement of memory, focus, learning, and mental clarity.
Research Evidence
Phase II trial in HIV lipodystrophy patients was discontinued after a patient death (MI, deemed unrelated but trial ended as precaution). Earlier studies show sustained 2-10 fold increase in GH and IGF-1 levels with good tolerability at doses up to 60 mcg/kg.
Dosing for Cognitive Enhancement
Recommended Dose
100-200 mcg daily
Frequency
Daily (no DAC) or 1-2x weekly (with DAC)
Administration
Subcutaneous injection
Duration
8-12 weeks
Note: No-DAC version requires daily dosing. DAC version has longer half-life. Often stacked with GHRP like Ipamorelin.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Injection site reactions
- •Facial flushing
- •Headache
- •Water retention
- •Dizziness
Frequently Asked Questions
Does CJC-1295 (No DAC) help with cognitive enhancement?
GH may support brain health and cognitive function.
How does CJC-1295 (No DAC) work for cognitive enhancement?
Growth hormone has effects on neuroplasticity....
What dose of CJC-1295 (No DAC) should I use for cognitive enhancement?
100-200 mcg daily
How long until I see results?
Cognitive effects over 4-8 weeks
Other Peptides for Cognitive Enhancement
These peptides are also researched for cognitive enhancement.
Ipamorelin
Clinical TrialsA selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.
GHRP-6
Clinical TrialsOne of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.
GHRP-2
Clinical TrialsA synthetic hexapeptide that potently stimulates GH release. More potent than GHRP-6 with less appetite stimulation, but still elevates cortisol and prolactin.
MK-677
Clinical TrialsAn orally active growth hormone secretagogue that mimics ghrelin. Although technically not a peptide, it is frequently discussed alongside GH peptides due to similar effects.